Gene · 3428
Papers2,876
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,876
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network medicine-based epistasis detection in complex diseases: ready for quantum computing. | medRxiv | 2023 | 38076997 | PubTator, text mining | PubMed |
| APOBEC3G Is a p53-Dependent Restriction Factor in Respiratory Syncytial Virus Infection of Human Cells Included in the p53/Immune Axis. | Int J Mol Sci | 2023 | 38069117 | PubTator, text mining | PubMed |
| NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases-A Lesson from Cytokine Storm Syndrome. | Int J Mol Sci | 2023 | 38068879 | PubTator, text mining | PubMed |
| Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression. | Cancer Cell Int | 2023 | 38066598 | PubTator, text mining | PubMed |
| Quantitative proteomics defines mechanisms of antiviral defence and cell death during modified vaccinia Ankara infection. | Nat Commun | 2023 | 38065956 | PubTator, text mining | PubMed |
| Identification of interferon-stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells. | Front Immunol | 2023 | 38058490 | PubTator, text mining | PubMed |
| Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial. | Cell Rep Med | 2023 | 38056464 | PubTator, text mining | PubMed |
| Differences in gene expression profiles in early and late stage rhodesiense HAT individuals in Malawi. | PLoS Negl Trop Dis | 2023 | 38055777 | PubTator, text mining | PubMed |
| Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. | Nat Commun | 2023 | 38042900 | PubTator, text mining | PubMed |
| Assembly mechanism of the inflammasome sensor AIM2 revealed by single molecule analysis. | Nat Commun | 2023 | 38042863 | PubTator, text mining | PubMed |
| Correction: USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16. | PLoS Pathog | 2023 | 38039266 | PubTator, text mining | PubMed |
| Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIVmac239 in rhesus macaques. | iScience | 2023 | 38025783 | PubTator, text mining | PubMed |
| Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation. | Front Immunol | 2023 | 38022619 | PubTator, text mining | PubMed |
| Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway. | Onco Targets Ther | 2023 | 38021448 | PubTator, text mining | PubMed |
| Single-cell transcriptomic atlas of distinct early immune responses induced by SARS-CoV-2 Proto or its variants in rhesus monkey. | MedComm (2020) | 2023 | 38020713 | PubTator, text mining | PubMed |
| Inflammasome pathway in kidney transplantation. | Front Med (Lausanne) | 2023 | 38020086 | PubTator, text mining | PubMed |
| MiR-155 Negatively Regulates Anti-Viral Innate Responses among HIV-Infected Progressors. | Viruses | 2023 | 38005883 | PubTator, text mining | PubMed |
| Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent. | Life (Basel) | 2023 | 38004271 | PubTator, text mining | PubMed |
| An Emerging Role for Anti-DNA Antibodies in Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 38003689 | PubTator, text mining | PubMed |
| IFI16 Induced by Direct Interaction between Esophageal Squamous Cell Carcinomas and Macrophages Promotes Tumor Progression via Secretion of IL-1α. | Cells | 2023 | 37998338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3428/papers?page=12